Page last updated: 2024-10-24

carmustine and Cardiac Death

carmustine has been researched along with Cardiac Death in 1 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Damia, G1
Komschlies, KL1
Futami, H1
Back, T1
Gruys, ME1
Longo, DL1
Keller, JR1
Ruscetti, FW1
Wiltrout, RH1

Other Studies

1 other study available for carmustine and Cardiac Death

ArticleYear
Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
    Cancer research, 1992, Aug-01, Volume: 52, Issue:15

    Topics: Animals; Antineoplastic Agents; Bone Marrow; Carboplatin; Carmustine; Cisplatin; Cyclophosphamide; D

1992